Little Green Pharma (ASX:LGP) Partners With Health Insurance Fund, Medicinal Cannabis To Be Benefitted

Perth-based Little Green Pharma (ASX:LGP) and national private health insurer, Health Insurance Fund of Australia have signed a strategic partnership which shall be responsible for expanding access to medicinal cannabis across the country. Post this partnership, HIF now is the first Australian heath fund to give thumbs up to medicinal cannabis treatments.  

The partnership also features research into medical cannabis, the companies declared.

Australia added up 5,972 medical cannabis approvals in October, making the total number of approvals in 2020 to over 45,000.

The HIF shall offer rebates for Little Green Pharma’s medical cannabis products up to A$105.

Meanwhile, the LGP stock traded at $0.400, up 2.56%, with a market capitalisation of $52.44 million at 2:44 PM AEDT.





Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK